CALR and neoplasm: Notably, elevated levels of key ICD markers-ATP, calreticulin (CRT), and HMGB1-were observed in the COF-606 + 808 nm group, indicating robust activation of immune responses within the tumor microenvironment and supporting the synergistic effect of PDT and immunotherapy.